Multi-Institutional Retrospective Study for the Efficacy of ICIs plus Platinum-Based Chemotherapy for EGFR Mutated NSCLC

被引：0
|
作者：
Kataoka, S. [1 ]
Miyawaki, T. [1 ]
Motojima, M. [2 ]
Shibayama, K. [1 ]
Nanba, Y. [2 ]
Mimori, T. [1 ]
Shukuya, T. [1 ]
Shimada, N. [1 ]
Koyama, R. [3 ]
Kido, K. [3 ]
Sasaki, S. [2 ]
Takahashi, K. [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[2] Juntendo Univ, Urayasu Hosp, Chiba, Japan
[3] Juntendo Univ, Nerima Hosp, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR mutated NSCLC; ICIs; retrospective study;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-04
引用
收藏
页码：S620 / S620
页数：1
相关论文
共 50 条
  • [1] Efficacy in the elderly NSCLC patients in SCORPION study: Phase II study of DTX plus RAM following platinum-based chemotherapy plus ICIs
    Yamaguchi, T.
    Matsuzawa, R.
    Morise, M.
    Ito, K.
    Hataji, O.
    Takahashi, K.
    Koyama, J.
    Kuwatsuka, Y.
    Goto, Y.
    Imaizumi, K.
    Itani, H.
    Zenke, Y.
    Oki, M.
    Ishii, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1678 - S1678
  • [2] Study Design of SCORPION: Multi-Center, Phase II Study Following Platinum-Based Chemotherapy Plus ICIs in Patients with NSCLC
    Matsuzawa, R.
    Morise, M.
    Ito, K.
    Hataji, O.
    Takahashi, K.
    Hara, T.
    Goto, Y.
    Imaizumi, K.
    Itani, H.
    Yamaguchi, T.
    Zenke, Y.
    Oki, M.
    Kogure, Y.
    Hashimoto, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1102 - S1103
  • [3] Multi-center, phase II study of docetaxel (DTX) plus ramucirumab (RAM) following platinum-based chemotherapy plus ICIs in patients with NSCLC: SCORPION study
    Matsuzawa, R.
    Morise, M.
    Ito, K.
    Hataji, O.
    Takahashi, K.
    Kuwatsuka, Y.
    Goto, Y.
    Imaizumi, K.
    Itani, H.
    Yamaguchi, T.
    Zenke, Y.
    Oki, M.
    Ishii, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S68 - S68
  • [4] Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2
    Lee, S. -H.
    Cho, B. C.
    Spira, A. I.
    Ou, S. -H. I.
    Waqar, S. N.
    Shah, S.
    Trani, L.
    Chu, P. -L.
    Thayu, M.
    Knoblauch, R. E.
    Bauml, J. M.
    Marmarelis, M. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S146 - S147
  • [5] EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy
    Shah, Manan P.
    Aredo, Jacqueline, V
    Padda, Sukhmani K.
    Ramchandran, Kavitha J.
    Wakelee, Heather A.
    Das, Millie S.
    Neal, Joel W.
    CLINICAL LUNG CANCER, 2022, 23 (02) : E148 - E153
  • [6] The efficacy of ICIs plus platinum-based chemotherapy for patients with advanced NSCLC and ECOG PS 2 (WJOG18424L): A propensity score-matched study
    Kataoka, S.
    Shukuya, T.
    Fujimoto, D.
    Ohtsu, H.
    Miyawaki, T.
    Toi, Y.
    Yokoyama, T.
    Kato, T.
    Yamaguchi, T.
    Miura, S.
    Tamiya, M.
    Tachihara, M.
    Otsubo, K.
    Sato, Y.
    Ikeda, S.
    Yamamoto, N.
    Takahashi, K.
    Hayashi, H.
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1646 - S1647
  • [7] Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study
    Rose, Kyle M.
    Pham, Rachel
    Zacharias, Niki M.
    Ionescu, Filip
    Paravathaneni, Mahati
    Marchetti, Kathryn A.
    Sanchez, Darren
    Mustasam, Arfa
    Sandstrom, Reagan
    Vikram, Raghu
    Dhillon, Jasreman
    Rao, Priya
    Schneider, Amy
    Pagliaro, Lance
    Alifrangis, Constantine
    Albersen, Maarten
    Roussel, Eduard
    Master, Viraj A.
    Nazha, Bassel
    Hernandez, Cindy
    Moses, Kelvin A.
    Protzel, Chris
    Montgomery, Jeffrey
    Angel, Martin
    Tobias-Machado, Marcos
    Spiess, Philippe E.
    Pettaway, Curtis A.
    Chahoud, Jad
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (06): : 966 - 973
  • [8] Sintilimab plus platinum-based chemotherapy for non-squamous NSCLC
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : E76 - E76
  • [9] Clinical and Radiological Predictors of Efficacy to Nivolumab in NSCLC: A Multi-Institutional, Retrospective Cohort Study
    Moor, R.
    Roberts, K.
    Ladwa, R.
    Miles, K.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S895 - S895
  • [10] OUTCOMES OF PLATINUM-SENSITIVE SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY RECHALLENGE: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS
    Genestreti, G.
    Metro, G.
    Kenmotsu, H.
    Carloni, F.
    Burgio, M. A.
    Casanova, C.
    Tiseo, M.
    Scarpi, E.
    Korkmaz, T.
    Califano, R.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S28 - S28
12345